Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive B-cell lymphoma (BCL) and a clinically and molecularly heterogeneous disease with a complex genetic background8,9. Recent large-scale genomic studies highlighted multiple potential driver alterations that co-occur and underscore the ...